Premium
Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease
Author(s) -
Klemke Markus,
Meyer Anke,
Nezhad Maliheh Hashemi,
Bartnitzke Sabine,
Drieschner Norbert,
Frantzen Christiane,
Schmidt Ernst Heinrich,
Belge Gazanfer,
Bullerdiek Jörn
Publication year - 2009
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.20627
Subject(s) - hmga2 , biology , uterine leiomyoma , downregulation and upregulation , uterine fibroids , pathogenesis , gene , cancer research , genetics , pathology , immunology , medicine , uterus , microrna
An overexpression of HMGA2 is supposed to be a key event in the genesis of leiomyoma with chromosomal rearrangements affecting the region 12q14‐15 targeting the HMGA2 gene, but gene expression data regarding differences between uterine leiomyomas with and those without 12q14‐15 aberrations are insufficient. To address the question whether HMGA2 is only upregulated in the 12q14‐15 subgroup, the expression of HMGA2 was analyzed in a comprehensive set of leiomyomas ( n = 180) including tumors with 12q14‐15 chromosomal aberrations ( n = 13) and matching myometrial tissues ( n = 51) by quantitative RT‐PCR. The highest expression levels for HMGA2 were observed in tumors with rearrangements affecting the region 12q14‐15, but although HMGA2 is expressed at lower levels in leiomyomas without such aberrations, the comparison between the expression in myomas and matching myometrial tissues indicates a general upregulation of HMGA2 regardless of the presence or absence of such chromosomal abnormalities. The significant ( P < 0.05) overexpression of HMGA2 also in the group of fibroids without chromosomal aberrations of the 12q14‐15 region suggests a general role of HMGA2 in the development of the disease. © 2008 Wiley‐Liss, Inc.